Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
High Court Order Preceded The Recall The recall followed an interim High Court order granted the previous month in litigation brought by Danish pharmaceutical company Novo Nordisk
Body Composition Changes During Weight Reduction With Tirzepatide in the SURMOUNT-1 Study. *Diabetes, Obesity and Metabolism*, 2025
And Novo Nordisk is dealing with fresh scrutiny from activist hedge fund Parvus Asset Management, which has quietly built a stake in the company and reportedly hopes to influence the CEO succession a move that briefly lifted Novo Nordisks stock on speculation about boardroom shakeups
The initial search yielded 1,929 records (PubMed: 29
Some studies report slight improvements in blood lipids or glucose levels, while others find little difference from the placebo group
US$ 23.56
US$ 28.64
US$ 19.99
US$ 27.82
